GO:0050804 modulation of chemical synaptic transmission: Synaptic Plasticity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050804 describes any process that changes the frequency or amplitude of chemical synaptic transmission, the fundamental communication event between neurons and their targets.
• Modulation can be mediated by neurotransmitters, neuromodulators, endocannabinoids, and aminergic systems that act on presynaptic or postsynaptic targets.
• Key molecular players include muscarinic acetylcholine receptors (M1/M2), AMPA receptors and their auxiliary subunit TARP gamma-8, and endocannabinoid receptors such as CB1.
• Dysregulation of synaptic transmission modulation contributes to chronic pain, peripheral inflammation-induced nociceptive changes, and other neurological conditions.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of genes involved in synaptic modulation.
• Understanding GO:0050804 is essential for neuroscience, drug discovery, and developing therapies for synaptic disorders.
Description
Chemical synaptic transmission is the primary means by which neurons communicate with each other and with target cells such as muscles or secretory cells. The Gene Ontology term GO:0050804, modulation of chemical synaptic transmission, encompasses any process that regulates the frequency or amplitude of this communication. This regulation is critical for information processing, learning, memory, and appropriate behavioral responses. Researchers studying synaptic function need to understand how modulation occurs because disruptions in these processes underlie numerous neurological and psychiatric disorders. The term includes both presynaptic and postsynaptic mechanisms, as well as the actions of neuromodulators that fine-tune synaptic strength. Experimental evidence from diverse model systems, including the lobster stomatogastric ganglion and mammalian spinal cord, has revealed that modulation can be achieved through aminergic, cholinergic, and endocannabinoid signaling pathways. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0050804, its molecular players, and the research methods used to study it.
modulation of chemical synaptic transmission At A Glance
| GO ID | GO:0050804 |
|---|---|
| GO term | modulation of chemical synaptic transmission |
| Ontology | biological_process |
| Synonym | modulation of synaptic transmission; regulation of chemical synaptic transmission; regulation of synaptic transmission |
| Major function | Regulation of the frequency or amplitude of synaptic transmission |
| Related cellular component | Synapse, presynaptic terminal, postsynaptic density |
| Related molecular function | Neurotransmitter receptor activity, neuromodulator receptor binding |
| Key physiological role | Synaptic plasticity, pain sensitization, neuromuscular control |
| Research relevance | Target for neurological and psychiatric disorders, drug development |
What Is GO:0050804?
According to the Gene Ontology, GO:0050804 (modulation of chemical synaptic transmission) is defined as any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission. In simpler terms, it is the set of biological mechanisms that adjust how strongly or how often a synapse communicates, without necessarily changing the fundamental machinery of neurotransmitter release and reception.
Why Is modulation of chemical synaptic transmission Important in Cell Biology?
Modulation of chemical synaptic transmission is fundamental to all nervous system functions, from simple reflexes to complex cognitive processes. It allows neural circuits to adapt to changing internal and external environments, a property known as synaptic plasticity. Dysregulation of this process is implicated in chronic pain, where increased gain in pain pathways results from altered synaptic modulation. Peripheral inflammation can affect modulation of nociceptive synaptic transmission in the spinal cord, highlighting the role of synaptic modulation in inflammatory pain. Furthermore, understanding how neuromodulators such as endocannabinoids and aminergic substances control synaptic strength provides insights into potential therapeutic targets for neurological disorders. The study of GO:0050804 is therefore essential for both basic neuroscience and translational medicine.
• Underlies synaptic plasticity, learning, and memory.
• Critical for pain sensitization and chronic pain states.
• Involved in neuromuscular transmission and its modulation by muscarinic receptors.
• Mediated by endocannabinoids that can potentiate both electrical and chemical synaptic transmission.
• Regulated by aminergic systems in central pattern generators.
• Target of therapeutic drugs such as TARP gamma-8-selective AMPA receptor modulators.
• Dysregulated in peripheral inflammation and nociceptive processing.
• Essential for understanding neuromodulation in excitable neurons.
• Provides a framework for CRISPR-based functional studies of synaptic genes.
• Relevant to drug discovery for neurological and psychiatric conditions.
What Happens During modulation of chemical synaptic transmission?
Presynaptic modulation of neurotransmitter release
In simple terms: The sending neuron can adjust how much neurotransmitter it releases.
Presynaptic modulation alters the probability of neurotransmitter release or the amount of neurotransmitter released per action potential. This can occur through activation of presynaptic receptors, such as muscarinic acetylcholine receptors, which balance neuromuscular synaptic transmission during inhibition of cholinesterases. Endocannabinoids can also act presynaptically to potentiate electrical and chemical synaptic transmission. Aminergic modulation in the lobster stomatogastric ganglion demonstrates that graded synaptic transmission can be regulated by amines.
Postsynaptic modulation of receptor sensitivity
In simple terms: The receiving neuron can change how strongly it responds to neurotransmitter.
Postsynaptic modulation involves changes in the number, composition, or properties of neurotransmitter receptors. For example, TARP gamma-8-selective AMPA receptor therapeutics modulate AMPA receptor function, affecting synaptic strength. This type of modulation can alter the amplitude of postsynaptic potentials, thereby changing the gain of synaptic transmission.
Neuromodulator action on synaptic transmission
In simple terms: Chemical messengers like endocannabinoids or amines fine-tune synaptic communication.
Neuromodulators such as endocannabinoids, amines, and neuropeptides can modulate synaptic transmission by activating G-protein-coupled receptors. Endocannabinoids potentiate electrical and chemical synaptic transmission in certain circuits. Aminergic modulation of graded synaptic transmission has been characterized in the lobster stomatogastric ganglion. N-arachidonoylphosphatidylethanolamine modulates nociceptive synaptic transmission in the spinal cord under peripheral inflammation.
Activity-dependent synaptic plasticity
In simple terms: Synapses can strengthen or weaken based on their recent activity.
Activity-dependent plasticity, such as long-term potentiation and long-term depression, is a form of modulation of chemical synaptic transmission. Neuronal plasticity increases the gain in pain pathways, illustrating how activity-dependent changes can lead to persistent pain states. This plasticity involves both presynaptic and postsynaptic mechanisms and is essential for learning and memory.
Modulation of synaptic transmission in disease and inflammation
In simple terms: Inflammation and disease can change how synapses work.
Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord, leading to altered pain sensitivity. This demonstrates that pathological states can hijack normal modulatory mechanisms. Understanding these changes is crucial for developing treatments for chronic pain and inflammatory conditions.
Key Genes Involved in GO:0050804 modulation of chemical synaptic transmission
The following genes and proteins are key players in the modulation of chemical synaptic transmission, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHRM1 | M1 muscarinic acetylcholine receptor; mediates balanced modulation of neuromuscular synaptic transmission | Target for modulating synaptic transmission during cholinesterase inhibition |
| CHRM2 | M2 muscarinic acetylcholine receptor; involved in presynaptic inhibition of neurotransmitter release | Studied in neuromuscular junction modulation |
| CNR1 | Cannabinoid receptor 1; mediates endocannabinoid effects on synaptic transmission | Key for understanding endocannabinoid modulation of electrical and chemical synapses |
| GRM1 | Metabotropic glutamate receptor 1; modulates synaptic transmission in pain pathways | Implicated in nociceptive synaptic plasticity |
| GRM5 | Metabotropic glutamate receptor 5; modulates synaptic transmission and pain sensitization | Target for chronic pain research |
| CACNA1B | Voltage-gated calcium channel subunit; controls neurotransmitter release | Modulated by presynaptic receptors |
| SCN1A | Voltage-gated sodium channel subunit; affects neuronal excitability and synaptic transmission | Relevant to epilepsy and synaptic modulation |
| GABRA1 | GABA-A receptor subunit; mediates inhibitory synaptic transmission | Target for anxiolytics and anticonvulsants |
| GRIN1 | NMDA receptor subunit; critical for synaptic plasticity | Studied in learning and memory |
| GRIN2A | NMDA receptor subunit; modulates synaptic transmission and plasticity | Implicated in neurological disorders |
| GRIA1 | AMPA receptor subunit; mediates fast excitatory synaptic transmission | Target of TARP gamma-8-selective modulators |
| GRIA2 | AMPA receptor subunit; controls calcium permeability and synaptic strength | Studied in synaptic modulation |
| CACNG8 | TARP gamma-8; auxiliary subunit of AMPA receptors | Selective therapeutic target for AMPA receptor modulation |
| DLG4 | PSD-95; scaffolding protein at postsynaptic density | Organizes receptor signaling complexes |
| SLC6A4 | Serotonin transporter; regulates serotonergic synaptic transmission | Target for antidepressants |
| TH | Tyrosine hydroxylase; rate-limiting enzyme for dopamine synthesis | Aminergic modulation of synaptic transmission |
| GAD1 | Glutamate decarboxylase 1; synthesizes GABA | Inhibitory synaptic transmission |
How Is modulation of chemical synaptic transmission Regulated?
Modulation of chemical synaptic transmission is regulated at multiple levels. Presynaptically, autoreceptors and heteroreceptors control neurotransmitter release. Postsynaptically, receptor phosphorylation, trafficking, and auxiliary subunit composition regulate synaptic strength. Neuromodulators such as endocannabinoids act retrogradely to suppress or potentiate transmitter release. Aminergic systems modulate graded synaptic transmission in central pattern generators. In pathological conditions, peripheral inflammation can alter modulatory pathways in the spinal cord, leading to increased pain sensitivity. Additionally, neuronal plasticity mechanisms can increase the gain in pain pathways, representing a form of maladaptive regulation.
modulation of chemical synaptic transmission and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRM1/GRM5 | Chronic pain, nociceptive sensitization | Knockout mice, point mutation models |
| CNR1 | Pain, epilepsy, obesity | Knockout mice, conditional knock-in |
| CHRM1/CHRM2 | Myasthenia gravis, organophosphate poisoning | Knockout mice, overexpression models |
| CACNG8 | Neurological disorders, AMPA receptor dysfunction | Point mutation knock-in, knockout |
| SCN1A | Epilepsy, Dravet syndrome | Knock-in mice, iPSC-derived neurons |
Chronic pain and nociceptive sensitization
Modulation of chemical synaptic transmission in pain pathways is a key mechanism underlying chronic pain. Neuronal plasticity increases the gain in pain pathways, leading to hyperalgesia and allodynia. Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord, contributing to inflammatory pain. Targeting synaptic modulation is therefore a promising strategy for pain relief.
Neurological and psychiatric disorders
Dysregulation of synaptic transmission modulation is implicated in epilepsy, schizophrenia, depression, and anxiety. For example, voltage-gated sodium channel mutations (SCN1A) alter neuronal excitability and synaptic transmission, leading to epilepsy. Serotonergic modulation via SLC6A4 is targeted by antidepressants. Understanding these mechanisms is essential for developing new therapies.
Neuromuscular disorders
Modulation of neuromuscular synaptic transmission is critical for muscle control. Muscarinic receptors (M1 and M2) balance synaptic transmission during cholinesterase inhibition, which is relevant to myasthenia gravis and organophosphate poisoning. Targeting these receptors may provide therapeutic benefits.
Neurodegenerative diseases
Alterations in synaptic modulation contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's. AMPA receptor modulation via TARP gamma-8 is being explored as a therapeutic strategy. Endocannabinoid signaling, which modulates synaptic transmission, is also implicated in neuroprotection.
From modulation of chemical synaptic transmission-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X modulate synaptic transmission? | CRISPR knockout in primary neurons or cell lines |
| Does a specific point mutation alter synaptic modulation? | CRISPR point mutation knock-in |
| How does overexpression of gene Y affect synaptic strength? | CRISPR overexpression (e.g., CRISPRa) |
| What is the role of a receptor subunit in synaptic modulation? | Tagged knock-in for imaging |
| Can a drug target modulate synaptic transmission? | Pharmacological studies in knockout vs wild-type |
| What are the downstream effectors of synaptic modulation? | CRISPR library screening |
How to Study the modulation of chemical synaptic transmission Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Synaptic currents, membrane potential | Quantifying modulation of synaptic transmission |
| Calcium imaging | Intracellular calcium transients | Presynaptic release and postsynaptic activity |
| Immunohistochemistry | Protein localization and expression | Synaptic protein distribution |
| Western blot | Protein levels and phosphorylation | Receptor regulation |
| CRISPR knockout | Loss-of-function effects | Gene function in synaptic modulation |
| CRISPR knock-in | Mutant protein expression | Point mutation effects |
| RNA-seq | Transcriptional changes | Identifying genes involved in synaptic modulation |
| Proteomics | Protein interactions and modifications | Synaptic proteome analysis |
Electrophysiology
Patch-clamp and voltage-clamp recordings measure the frequency and amplitude of synaptic currents and potentials, directly assessing modulation of chemical synaptic transmission. These techniques are essential for quantifying presynaptic release probability and postsynaptic receptor sensitivity.
Imaging and fluorescence microscopy
Fluorescent indicators of calcium, pH, or membrane potential (e.g., synaptopHluorin, GCaMP) allow real-time visualization of synaptic vesicle release and postsynaptic responses. These methods reveal spatial and temporal dynamics of synaptic modulation.
Molecular and biochemical assays
Western blotting, co-immunoprecipitation, and FRET/BRET can detect protein-protein interactions and post-translational modifications that regulate synaptic transmission. For example, phosphorylation of AMPA receptor subunits modulates synaptic strength.
Genetic and CRISPR-based screens
CRISPR knockout, knock-in, and overexpression libraries enable systematic interrogation of genes involved in synaptic modulation. High-throughput screening can identify novel modulators of synaptic transmission.
How CRISPR Can Be Used to Study GO:0050804 modulation of chemical synaptic transmission
Knockout
CRISPR knockout is used to eliminate expression of genes such as CHRM1, CNR1, or GRIA1 to determine their necessity in modulating synaptic transmission. For example, knockout of muscarinic receptors can reveal their role in neuromuscular synaptic balance. Knockout models are also valuable for validating drug targets like TARP gamma-8.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions to study structure-function relationships. For instance, mutating phosphorylation sites in AMPA receptor subunits can reveal their role in synaptic plasticity. This approach is ideal for modeling human disease-associated mutations.
Knock-in
CRISPR knock-in can insert reporter tags (e.g., GFP) or disease-relevant alleles. Tagged knock-in of synaptic proteins allows real-time imaging of their trafficking and localization. Knock-in of mutant SCN1A can model Dravet syndrome and study synaptic modulation defects.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to increase gene expression. Overexpressing endocannabinoid receptors or muscarinic receptors can enhance or disrupt synaptic modulation, providing insights into gain-of-function mechanisms. This approach is useful for studying synaptic saturation and compensation.
How EDITGENE Supports modulation of chemical synaptic transmission Research
Researchers studying modulation of chemical synaptic transmission-related genes often need to determine whether a candidate gene is causally involved in synaptic regulation or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from gene knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for modulation of chemical synaptic transmission research.
Frequently Asked Questions About modulation of chemical synaptic transmission
What is GO:0050804 modulation of chemical synaptic transmission?
GO:0050804 is a Gene Ontology biological process term that describes any process that modulates the frequency or amplitude of chemical synaptic transmission, the communication from a neuron to a target cell across a synapse.
What genes are involved in modulation of chemical synaptic transmission?
Key genes include CHRM1, CHRM2, CNR1, GRIA1, GRIA2, CACNG8, GRM1, GRM5, and SCN1A, among others.
How is modulation of chemical synaptic transmission studied?
It is studied using electrophysiology, imaging, molecular assays, and CRISPR-based genetic screens.
Why is modulation of chemical synaptic transmission important?
It underlies synaptic plasticity, learning, memory, and pain sensitization, and its dysregulation contributes to neurological disorders.
What diseases are associated with abnormal modulation of chemical synaptic transmission?
Chronic pain, epilepsy, myasthenia gravis, and neurodegenerative diseases are associated with altered synaptic modulation.
What is the role of endocannabinoids in modulation of chemical synaptic transmission?
Endocannabinoids can potentiate electrical and chemical synaptic transmission by acting on presynaptic CB1 receptors.
How do muscarinic receptors modulate synaptic transmission?
M1 and M2 muscarinic receptors balance neuromuscular synaptic transmission during inhibition of cholinesterases.
What is TARP gamma-8 and how does it modulate synaptic transmission?
TARP gamma-8 is an auxiliary subunit of AMPA receptors that modulates receptor trafficking and function, and is a target for selective therapeutics.
Can CRISPR be used to study modulation of chemical synaptic transmission?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of genes involved in synaptic modulation.
What are the synonyms for GO:0050804?
Synonyms include modulation of synaptic transmission, regulation of chemical synaptic transmission, and regulation of synaptic transmission.
Conclusion
GO:0050804 modulation of chemical synaptic transmission is a fundamental biological process that regulates the strength and frequency of communication across synapses. It involves a complex interplay of presynaptic and postsynaptic mechanisms, neuromodulators, and receptor signaling pathways. Dysregulation of this process is linked to chronic pain, epilepsy, and other neurological disorders. Advances in CRISPR-based gene editing and high-throughput screening are accelerating the discovery of new modulators and therapeutic targets. EDITGENE offers comprehensive services to support researchers in dissecting the genetic basis of synaptic modulation, from knockout to overexpression and library screening.
References
- 1. Woolf CJ et al.. 2000. Neuronal plasticity: increasing the gain in pain.. Science 288(5472):1765-9 PMID: 10846153
- 2. Lenina OA et al.. 2022. Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.. Sci Rep 12(1):1688 PMID: 35105922
- 3. Cachope R et al.. 2007. Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.. Neuron 56(6):1034-47 PMID: 18093525
- 4. Johnson BR et al.. 1990. Aminergic modulation of graded synaptic transmission in the lobster stomatogastric ganglion.. J Neurosci 10(7):2066-76 PMID: 2165519
- 5. Castellucci VF et al.. 1999. The chemical synapse: mechanisms of transmission and modulation.. Can J Physiol Pharmacol 77(9):631-3 PMID: 10566940
- 6. Chen Y et al.. 2024. Neuronomodulation of Excitable Neurons.. Neurosci Bull 40(1):103-112 PMID: 37584858
- 7. Nerandzic V et al.. 2018. Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.. Br J Pharmacol 175(12):2322-2336 PMID: 28476070
- 8. Zhang D et al.. 2023. Modulatory mechanisms of TARP γ8-selective AMPA receptor therapeutics.. Nat Commun 14(1):1659 PMID: 36966141
